Melina Rodriguez: First FDA-Approved VWD Prophylaxis for All Ages
Melina Rodriguez, Founder of Health Evidence Digest, Senior Medical Editor at Precision AQ, shared a post on LinkedIn:
“Von Willebrand Disease Is the Most Common Inherited Bleeding Disorder in the World. In Young Children With Severe Disease, Prophylactic Treatment Has Lacked Any FDA-Approved Option Until Now
On July 2, 2026, the FDA expanded Wilate (von Willebrand Factor/Coagulation Factor VIII Complex Human, Octapharma) approval to include routine prophylaxis in children younger than 6 years with von Willebrand disease, making it the first and only VWF concentrate approved for prophylaxis across all ages and all VWD types.
The Phase 3 WIL-33 trial (NCT04953884; n equals 12; median age 2.0 years; severe VWD) showed a mean total ABR of 4.6 (SD 6.1) during 12 months of prophylaxis; spontaneous ABR 0.9; 98.2% of all bleeds were minor; 95.6% of treated bleeds required only 1 infusion.
This was the first dedicated prospective clinical trial of VWF prophylaxis in children under 6 worldwide.
Here is what VWD is, why prophylaxis matters for young children with severe disease, and what the WIL-33 data shows across VWD types….”
Stay updated with Hemostasis Today.
-
Nov 4, 2026, 18:57Connecting Haemophilia Centres, Certifying Treaters, and Improving National Data in Romania – EHC
-
Nov 4, 2026, 18:45Smitirupa Mishra: A Practical Guide to Coagulation Pathway Assessment and Laboratory Interpretation
-
Nov 4, 2026, 15:59Alessandra Bosch: A Successful Patient Day for the Bleeding Disorders Community in Zürich
-
Nov 4, 2026, 15:47Wolfgang Miesbach: Targeting Hepatic Endothelial Cells for Lentiviral Gene Therapy in Haemophilia A
-
Nov 4, 2026, 15:20Augustina Isioma Ikusemoro: Before You Transfuse, Think PBM
-
Nov 4, 2026, 14:23Advancing Hemophilia Care Through Global Research – WFH
-
Nov 4, 2026, 14:12Jean-Jacques Kiladjian: From JAK Inhibitor-Associated Skin Cancers to Laboratory Discovery
-
Nov 4, 2026, 13:59Rita Li: ASH 2026 Abstract Achievement Award for Gut Microbiome Research
-
Nov 4, 2026, 13:38Omid Seidizadeh: Improving Access to von Willebrand Disease Diagnosis and Treatment Across Europe